REKHA CHERUVATTATH

Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology SACRAMENTO, CA NPI 1891779740

General Payments — all program years on this page

$1,597.68

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 84
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $505.61 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $505.6120

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $277.3818
2019 $109.097
2020 $16.301
2021 $61.473
2022 $368.8824
2023 $258.9511
2024 $505.6120

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078321951 Janssen Biotech, Inc. $18.77 03/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078322840 Janssen Biotech, Inc. $17.81 08/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092740039 Boston Scientific Corporation $18.62 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103457146 ABBVIE INC. $23.64 02/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103457148 ABBVIE INC. $18.88 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114023976 Regeneron Healthcare Solutions, Inc. $21.15 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131969790 PFIZER INC. $13.53 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137510062 Takeda Pharmaceuticals U.S.A., Inc. $16.00 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137510066 Takeda Pharmaceuticals U.S.A., Inc. $24.02 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137510070 Takeda Pharmaceuticals U.S.A., Inc. $13.28 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137510074 Takeda Pharmaceuticals U.S.A., Inc. $20.75 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139957153 GENZYME CORPORATION $23.92 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139957225 GENZYME CORPORATION $15.74 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144163339 Madrigal Pharmaceuticals $131.33 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144163341 Madrigal Pharmaceuticals $17.02 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146675198 Ardelyx, Inc. $23.68 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151049180 Phathom Pharmaceuticals, Inc. $16.60 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153460815 Salix Pharmaceuticals, a division of Bausch Health US, LLC $15.85 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153599075 Salix Pharmaceuticals, a division of Bausch Health US, LLC $23.03 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153678348 Salix Pharmaceuticals, a division of Bausch Health US, LLC $31.99 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.